Lazard Asset Management LLC Uro Gen Pharma Ltd. Transaction History

Lazard Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$10.87 - $15.93 $32,142 - $47,105	-2,957 Reduced 89.31%	354 $5,000
Q3 2023 Nov 14, 2023	BUY	$8.84 - $22.64 $29,269 - $74,961	3,311 New	3,311 $46,000
Q4 2022 Feb 14, 2023	BUY	$7.55 - $11.96 $23,488 - $37,207	3,111 New	3,111 $27,000
Q4 2021 Feb 09, 2022	SELL	$9.03 - $19.13 $29,627 - $62,765	-3,281 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$14.31 - $18.39 $46,951 - $60,337	3,281 New	3,281 $55,000

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $257M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.